Complement C1q subcomponent subunit C precursor. [Source:Uniprot/SWISSPROT;Acc:P02747] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
3M Imidazole Solution 125 ml...
PFM8 Antibody...
Goat polyclonal to DDDDK tag (FITC) ( Abpromise for all tested applications)....
Biology Products:(Date:12/2/2009)... New study results strengthen the evidence that people who ... an increased risk for developing colorectal cancer, even after ... one more reason not to smoke, or to quit ... Thun, M.D., M.S., vice president emeritus, epidemiology and surveillance ...
(Date:12/2/2009)... exposed to cigarette smoking scenes in movies are ... and this may be part of the acculturation ... study findings. , "Our study supports an R-rating ... the global implementation of the World Health Organization ...
(Date:12/2/2009)... WEST LAFAYETTE, Ind. ╤ A Smoky Mountain forest,s woodland ... role in how forest understories recover from logging, according ... portions of the forest nearly 80 years ago, the ... was similar to that of undisturbed areas. Michael Jenkins, ...
Breaking Biology News(10 mins):Cigarette smoking increases colorectal cancer risk 2Watching movies featuring characters who smoke negatively influences Mexican-American teens 2Study finds logging effects vary based on a forest's history, climate 2Bayer Schering Exercises Option to Develop Solid Tumor BiTE Antibody with Micromet 6615 1Bayer Schering Exercises Option to Develop Solid Tumor BiTE Antibody with Micromet 6615 2Bayer Schering Exercises Option to Develop Solid Tumor BiTE Antibody with Micromet 6615 3Bayer Schering Exercises Option to Develop Solid Tumor BiTE Antibody with Micromet 6615 4Silicon Valley Veteran Launches New Venture on the 26amp 3B 238220 3BnanoEdge 26amp 3B 238221 3B of the Emerging Nanotechnology Revolution 15007 1Silicon Valley Veteran Launches New Venture on the 26amp 3B 238220 3BnanoEdge 26amp 3B 238221 3B of the Emerging Nanotechnology Revolution 15007 2Silicon Valley Veteran Launches New Venture on the 26amp 3B 238220 3BnanoEdge 26amp 3B 238221 3B of the Emerging Nanotechnology Revolution 15007 3Silicon Valley Veteran Launches New Venture on the 26amp 3B 238220 3BnanoEdge 26amp 3B 238221 3B of the Emerging Nanotechnology Revolution 15007 4Estes Audiology Offers the Gift of Hearing to Celebrate the Holiday Season 62326 1Estes Audiology Offers the Gift of Hearing to Celebrate the Holiday Season 62326 2(Date:12/3/2009)... INC. (OTC Bulletin Board: ACCP), ... of MuGard, an FDA approved treatment for oral mucositis, ... MuGard is commercially launched by Access, partner, SpePharm, in ... Greece and Sweden. Access is conducting pre-marketing activities, including ...
(Date:12/3/2009)... Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) today announced ... quarter of fiscal year 2010 on December 10, 2009 at ... webcast to discuss the results at 11:30 a.m. EST on ... results for the second quarter ended October 31, 2009 and ...
(Date:12/3/2009)... -- Dr. Susan Jiang, M.D., Ph.D.,Chief Science Officer ... ), spoke at a conference on High-Risk Diabetic,Foot ... Beike is China,s leading,stem cell research and regenerative ... conference, organized by the Indian Podiatry Association (IPA), ...
(Date:12/2/2009)... NEW YORK, Dec. 2 Reportlinker.com announces ... available in its catalogue: ,, Neurostimulation ... http://www.reportlinker.com/p0164232/Neurostimulation---A-Global-Market-Perspective.html ,, The world ... base of aging population, and the resultant ...
Breaking Biology Technology:Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 4Peregrine Pharmaceuticals to Report Second Quarter FY 2010 Financial Results 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3Reportlinker Adds Neurostimulation - A Global Market Perspective 2Reportlinker Adds Neurostimulation - A Global Market Perspective 3Reportlinker Adds Neurostimulation - A Global Market Perspective 4Reportlinker Adds Neurostimulation - A Global Market Perspective 5Reportlinker Adds Neurostimulation - A Global Market Perspective 6